Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RAB3IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARL2BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TM4SF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CLCN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFATC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASH2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACVR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2S3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3945HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NSMCE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YBX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on